AC Immune (ACIU) vs Yarrow Bioscience, Inc (YARW)
AC Immune and Yarrow Bioscience, Inc are both Biotechnology companies. AC Immune and Yarrow Bioscience, Inc are of similar size ($249.4M and $246.0M). Yarrow Bioscience, Inc grew revenue faster over the last twelve months: 1.26% against −85.6%. AC Immune has the higher net margin (−1,783.7% vs −3,881.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Yarrow Bioscience, Inc leads on 8 and AC Immune on 7.
Valuation
Profitability
| Metric | ACIU | YARW | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (1,745.75%) | (4,134.44%) | 0.00% |
| Net margin | (1,783.66%) | (3,881.54%) | 0.00% |
| Free cash flow margin | 0.00% | (3,513.07%) | 0.00% |
| Return on equity | 0.00% | (61.40%) | (57.72%) |
| Return on assets | 0.00% | (54.77%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack